Guillain-Barré syndrome related to SARS-CoV-2 infection
Kévin Bigaut, Martial Mallaret, Seyyid Baloglu, Benjamin Némoz, Patrice Morand, Florent Baicry, Alexandre Godon, Paul Voulleminot, Laurent Kremer, Jean‐Baptiste Chanson, de Sèze
Abstract
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for coronavirus disease 2019 (COVID-19) led to the death of thousands of people around the world.1 Neurologic manifestations are not much specific apart from acute anosmia, and postinfectious manifestation data are missing.2 We described the cases of 2 patients exhibiting demyelinating form of Guillain-Barré syndrome (GBS) and summarized neurologic manifestations and investigations results in table 1.
Topics & Concepts
AnosmiaGuillain-Barre syndromeOutbreakMedicineCoronavirusDysgeusiaCoronavirus disease 2019 (COVID-19)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseImmunologyPediatricsPathologyInfectious disease (medical specialty)Internal medicineAdverse effectLong-Term Effects of COVID-19Peripheral Neuropathies and DisordersRetinal and Optic Conditions